Busulfan-Induced Infertility May Deter Some Pediatric Patients From Bluebird, Other Gene Therapies

Partial Hold On Firm's Sickle Cell Therapy Lifted

 
• By Alaric DeArment
  
Bluebird said 19 December the FDA had lifted a partial hold on its lovo-cel trial • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Gene Therapies

More from Advanced Therapies